‘Cyberpunk 2077’ QA lead leaves the developer after 11 years – NME

The quality assurance (QA) lead at Cyberpunk 2077developer CD Projekt Red has announced they are leaving the company.

ukasz Babiel announced the news on his Twitter, saying: I really worked with the best people.

The veteran member of CD Projekt Red worked at the company for 11 years and helped develop games such as Gwent, The Witcher 3: Wild Hunt, and Cyberpunk 2077.

In a Tweet that confirmed the news, Babiel said. Last month I decided to leave CD Projekt RED after [a] great 11 years there. Ive got these amazing gifts as a farewell 3D printed and hand-painted figure and a comic by two talented Polish authors, which just melted my heart. I really worked with the best people.

He shared two images, one showing a custom figure displaying Babiel in Johnny Silverhands outfit from Cyberpunk 2077and a comic page that used his likeness.

Babiel started at CD Projekt Red in 2010 when he joined the developer as a beta tester. He then continued to become the Cyberpunk 2077 QA lead in 2017. During his time in this role, he managed a team of over 60 employees, planned testing, introduced pipelines, and worked closely with lead produces and studio directors, according to his LinkedIn.

A recent mod added survival game mechanics to Cyberpunk 2077. Called Live In Night City, the mod adds fatigue, hunger, and thirst levels. If the players needs arent met, they will suffer stat penalties. If fatigue gets too high, which comes from not sleeping or taking a shower, critical hit chance and stamina regeneration suffer. System malfunctions can also occur, creating flashes or forcing the player to the ground on normal/hard difficulty.

In other news, a vulnerability in Dark Souls 3 has been discovered that could allow bad actors to execute code on another players PC. Though the exploit can be guarded against with anti-cheat software, the problem could also impact next months in Elden Ring.

Continued here:

'Cyberpunk 2077' QA lead leaves the developer after 11 years - NME